Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb
暂无分享,去创建一个
Ignacio Blanco | Eduard Serra | Conxi Lázaro | Elisabeth Castellanos | C. Lázaro | E. Serra | C. Carrato | Isabel Bielsa | Cristina Carrato | Imma Rosas | Ares Solanes | Cristina Hostalot | Emilio Amilibia | José Prades | Francesc Roca-Ribas | I. Bielsa | E. Castellanos | C. Hostalot | E. Amilibia | F. Roca-Ribas | J. Prades | I. Rosas | A. Solanes | Ignacio Blanco
[1] F. Baas,et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. , 2007, American journal of human genetics.
[2] E. Bröcker,et al. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? , 2003, The British journal of dermatology.
[3] D. Evans,et al. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis , 2012, neurogenetics.
[4] D. Evans,et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas , 2010, Oncogene.
[5] A. Stemmer-Rachamimov,et al. Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic Schwannomas , 2008, Brain pathology.
[6] D. Evans,et al. A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2? , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[7] A. Stemmer-Rachamimov,et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria , 2013, American journal of medical genetics. Part A.
[8] D. Evans,et al. An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2) , 2009, Journal of Medical Genetics.
[9] R. Sobel,et al. Somatic instability of the NF2 gene in schwannomatosis. , 2003, Archives of neurology.
[10] M. Genuardi,et al. Evidence of a four‐hit mechanism involving SMARCB1 and NF2 in schwannomatosis‐associated schwannomas , 2008, Human mutation.
[11] C. Bolger,et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis , 2008, Journal of Medical Genetics.
[12] D. Evans,et al. Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification , 2007, Journal of Medical Genetics.
[13] D. Evans,et al. Neurofibromatosis type 2 (NF2): diagnosis and management. , 2013, Handbook of clinical neurology.
[14] D. Evans,et al. Genetic testing and screening of individuals at risk of NF2 , 2012, Clinical genetics.
[15] Bruce R Korf,et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas , 2013, Nature Genetics.
[16] S. Olschwang,et al. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis , 2011, BMC neurology.
[17] L. Kluwe,et al. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis , 2008, Clinical genetics.
[18] J. Gusella,et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. , 1997, American journal of human genetics.